Endonovo's SofPulse® Secures Taiwan FDA Approval
October 12, 2023 09:07 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) US-based medical device company, today announced the full regulatory approval of its flagship product,...
Endonovo’s SofPulse® Nears Final Stages to Receive Taiwan FDA License to Distribute in Taiwan
March 23, 2023 09:03 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, March 23, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) -- a medical device company known for its innovative and effective pain management solutions --...